Immunohistochemistry analyses showed that expression of ChAT in lung tissues of breast cancer patients with lung metastasis was significantly higher than that expressed in patients with non-tumor pulmonary diseases (Fig. 9), suggesting the role of ACh in remodeling of lung pre-metastatic niche in clinical settings. The gene discussed is CHAT; the disease is lung disorder.